SK
Scott Kellen
CFO & Secretary

Scott Kellen insider trades: DiaMedica Therapeutics (DMAC) stock purchases

CFO & Secretary, DiaMedica Therapeutics Last trade Jun 23, 2023 27 Form 4 filings
$0
Sold, last 12 months
0 sales
$0
Bought, last 12 months
0 buys
8
Open-market trades
since 2013
3
Companies
last trade 2023

Trades on the price chart

Daily close, with an arrow on each day they bought or sold

Companies

Where Scott reports to the SEC

Open-market buys and sales

8 trades reported on SEC Form 4, newest first

DateStockTypeValue
Jun 23, 2023DMAC↑ Buy$39K
Aug 16, 2021DMAC↑ Buy$31K
Nov 9, 2020DMAC↑ Buy$8K
Aug 19, 2019DMAC↑ Buy$7K
May 24, 2019DMAC↑ Buy$12K
Dec 11, 2018DMAC↑ Buy$5K
Aug 30, 2013KIPS↑ Buy$8K
Aug 12, 2013KIPS↑ Buy$8K

Each row is one filing's trades in one stock, summed. Shares and prices are as filed, before any later stock split.

Other DMAC insiders

Open-market trades in the last 12 months

About Scott Kellen's insider trades

Scott Kellen is CFO & Secretary at DiaMedica Therapeutics (DMAC). Since Aug 12, 2013, Scott has reported 8 open-market purchases worth $119K and no sales on SEC Form 4. There have been no open-market trades in the last 12 months.

Their filings also include grants and awards (17 filings), other transactions (2 filings). These aren't open-market trades and aren't counted above.

How to read insider trades

Officers, directors and owners of more than 10% of a company must report trades in its stock on SEC Form 4, usually within two business days. Purchases with their own money are the stronger signal: insiders sell for many reasons (taxes, diversification, a house), but buy for one. See every DMAC insider trade, the latest insider trades across the market, or cluster buys, when several insiders buy the same stock within days.